NCT03651089View on ClinicalTrials.gov

SP16 SERPIN-like Peptide Administration in Healthy Individuals

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 16, 2018

Primary Completion Date

January 15, 2019

Study Completion Date

January 23, 2019

Conditions
Healthy Participants
Interventions
DRUG

SP16

subcutaneous injection of experimental anti-inflammatory drug

DRUG

Placebos

subcutaneous injection of sterile saline

Trial Locations (1)

23298

Virginia Commonwealth University, Richmond

All Listed Sponsors
collaborator

George Mason University

OTHER

collaborator

Virginia Commonwealth University

OTHER

lead

Serpin Pharma, LLC

OTHER

NCT03651089 - SP16 SERPIN-like Peptide Administration in Healthy Individuals | Biotech Hunter | Biotech Hunter